Metabolomics in Drug Discovery

Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in Drug Development

Related Conference of Metabolomics in Drug Discovery

February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
June 27-28, 2023

3rd Annual Summit on Advanced Bionics

Vienna, Austria
September 21-22, 2023

19th World Congress on Structural Biology

Paris, France
September 21-22, 2023

14th International Conference on Biofuels and Bioenergy

Toronto, Canada
October 23-24, 2023

27th European Biotechnology Congress

Rome, Italy
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy

Metabolomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in